BREAKING
OpenEvidence eyes $20B valuation
0
M
potential raise
0
B
valuation
0
B
January valuation
Valuation jumps in one year
Feb 25
1
Jul
3.5
Oct
6
Jan
12
Now
20
0
%
US physicians
0
M
consultations
0
+
hospitals
Momentum vs open questions
Strengths
●
4.9/5 App Store rating
●
Faster than UpToDate
●
NEJM AI partner
Concerns
●
Accuracy on complex cases
●
Legal liability risk
●
Ad-driven revenue
Offers on table, no deal yet
AI NEWS BLITZ
Medical AI startup OpenEvidence is weighing a new raise at a twenty billion dollar valuation.